SENS - Senseonics Holdings, Inc.
6.105
-0.765 -12.531%
Share volume: 829,979
Last Updated: 03-05-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$6.87
-0.76
-0.11%
Fundamental analysis
42%
Profitability
35%
Dept financing
43%
Liquidity
75%
Performance
40%
Performance
5 Days
-26.71%
1 Month
-17.83%
3 Months
-8.61%
6 Months
-2.48%
1 Year
-2.48%
2 Year
-2.48%
Key data
Stock price
$6.10
DAY RANGE
$6.01 - $6.81
52 WEEK RANGE
$5.25 - $8.75
52 WEEK CHANGE
-$2.48
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Timothy T. Goodnow
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing
Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics is headquartered in Germantown, Maryland, and serves healthcare providers and patients through a network of distributors.
Recent news